Alamar Biosciences, Inc.
28.96USD
-0.9900 (-3.31%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | 29 | 26 | 16 | 13 |
| Cost of Revenue | 12 | 12 | 8 | 7 |
| Gross Profit | 18 | 14 | 9 | 6 |
| Operating Income | -14 | -12 | -8 | -9 |
| Net Income | -13 | -21 | -7 | -8 |
| EPS (Diluted) | $-0.22 | $-1.74 | $-0.62 | $-0.68 |
Source: SEC filings (EDGAR)